Skip to main content
Market intelligence
GLUEHealthcare

Monte Rosa Therapeutics Inc insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jun 24, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jun 24, 2026Filip JankuChief Medical OfficerSale41,845$21.08$882,201
Jun 23, 2026Sharon TownsonChief Scientific OfficerSale3,000$20.00$60,000
Jun 23, 2026Jennifer ChampouxChief Operating OfficerSale2,175$20.00$43,500